GD
49
4
FLS
41
4
MUR
33
4
PFE
33
5
TJX
55
4
EW
37
-4
CMA
56
4
TMO
42
2
CFG
68
8
NI
75
5
PSX
39
2
MKC
63
6
HIG
66
6
HPE
44
4
STI
29
8
CINF
53
2
HRB
55
3
NUE
47
3
GILD
64
2
LUV
57
3
GD
49
4
FLS
41
4
MUR
33
4
PFE
33
5
TJX
55
4
EW
37
-4
CMA
56
4
TMO
42
2
CFG
68
8
NI
75
5
PSX
39
2
MKC
63
6
HIG
66
6
HPE
44
4
STI
29
8
CINF
53
2
HRB
55
3
NUE
47
3
GILD
64
2
LUV
57
3
Financhill
Back

Cue Biopharma 10K Form

Sell
19

CUE
Cue Biopharma

Last Price:
$0.65
Seasonality Move:
-26.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CUE News And Ratings

See the #1 stock for the next 7 days that we like better than CUE

CUE Financial Statistics

Sales & Book Value

Annual Sales: $9.3M
Cash Flow: $-8.3M
Price / Cash Flow: 0
Annual Sales: $0.11
Price / Book: 7.34

Profitability

EPS (TTM): -0.67000
Net Income (TTM): $-40.6M
Gross Margin: --
Return on Equity: -200.7%
Return on Assets: -103.78%

Cue Biopharma Earnings Forecast

Key Cue Biopharma Financial Ratios

  • The Research & Development expenses have been 390.82% of Revenue.
  • The Net Earning history of CUE is -437.97% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 5 years.

Cue Biopharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CUE
CUSIP: 22978P
Website: cuebiopharma.com

Debt

Debt-to-Equity Ratio: 0.51
Current Ratio: 1.03
Quick Ratio: 0.85

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CUE Technical Analysis vs Fundamental Analysis

Sell
19
Cue Biopharma (CUE) is a Sell

Is Cue Biopharma a Buy or a Sell?

  • Cue Biopharma stock is rated a Sell
    The current Cue Biopharma [CUE] share price is $0.64. The Score for CUE is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.